A study reported the presence of rearrangement-positive cases for both ALK and ROS1 in human CRC specimens and was the first to demonstrate a similarly low but detectable rate of ROS1 rearrangement in CRC [119]. Here, ROS1 is linked to colorectal carcinoma.